Oriheal Pimotone 5mg is a prescription-only veterinary cardiovascular medication formulated for the clinical management and treatment of congestive heart failure (CHF) and advanced heart conditions in dogs and cats. The active pharmaceutical ingredient, Pimobendan, functions as a highly effective "inodilator" that delivers a crucial dual mechanism of action: it operates as a calcium sensitizer to directly improve heart muscle contractility (positive inotropy) while simultaneously acting as a phosphodiesterase III (PDE3) inhibitor to dilate peripheral blood vessels.

This dual action minimizes resistance in systemic blood pathways, reduces the afterload and overall workload on weak heart chambers, and optimizes total cardiac output without elevating oxygen consumption. In dogs, it is commonly prescribed to manage heart conditions resulting from Myxomatous Mitral Valve Disease (MMVD) or Dilated Cardiomyopathy (DCM). In feline patients, it is utilized as an off-label therapeutic option for advanced myocardial diseases such as restrictive or hypertrophic cardiomyopathy where systolic dysfunction is present. Administered orally on an empty stomach, Pimotone 5mg significantly eases debilitating clinical symptoms like chronic coughing, breathlessness, and lethargy, substantially boosting everyday stamina and extending life expectancy.